Latest News

11

February 2019

iX Biopharma Ltd. has reported results for the second financial quarter and first half-year ended 31st December 2018...

Read On

05

November 2018

iX Biopharma will be presenting its Wafermine Phase 2 study results at the Bio-Europe 24th Annual International Partnering Conference...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com